Cargando…

Expression of Tumor‐associated Glycoantigen, Sialyl Lewis(a), in Human Head and Neck Squamous Cell Carcinoma and Its Application to Tumor Immunotherapy

The glycoantigen sialyl Lewis(a) (sLe(a)) is widely expressed on a variety of gastrointestinal tumor cells. Here, we immunohistochemically demonstrated the expression of sLe(a) antigen in 54% (7 out of 13) of human head and neck squamous cell carcinoma (H‐NSCG) samples. Frequent expression of sLe(a)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makino, Koji, Ogata, Tetsuro, Miyake, Hirosato, Habu, Sonoko, Nishimura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1994
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919591/ https://www.ncbi.nlm.nih.gov/pubmed/7961115 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02964.x

Ejemplares similares

Sialyl-Lewis(X) Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy
por: Colomb, Florent, et al.
Publicado: (2020)

CRB1-Associated Retinal Dystrophy Patients Have Expanded Lewis Glycoantigen-Positive T Cells
por: Moekotte, Lude, et al.
Publicado: (2023)

Advances in the Immunomodulatory Properties of Glycoantigens in Cancer
por: da Costa, Valeria, et al.
Publicado: (2022)

Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
por: Trinchera, Marco, et al.
Publicado: (2017)

Interleukin‐12 Augments the Generation of Autologous Tumor‐reactive CD8(+) Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes
por: Kuge, Soichi, et al.
Publicado: (1995)

Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages
por: Ma, Zhi, et al.
Publicado: (2021)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion
Publicado: (1995)

Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells
por: Matsumoto, S, et al.
Publicado: (2002)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
por: Economopoulou, Panagiota, et al.
Publicado: (2020)

T cell effects and mechanisms in immunotherapy of head and neck tumors
por: Xiang, Yizhen, et al.
Publicado: (2023)

Sialyl Lewis(x)-P-selectin cascade mediates tumor–mesothelial adhesion in ascitic fluid shear flow
por: Li, Shan-Shan, et al.
Publicado: (2019)

Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma
por: Zhang, Jian, et al.
Publicado: (2020)

Identification of Sialyl-Lewis(x)-Interacting Protein on Human Spermatozoa
por: Wang, Ying, et al.
Publicado: (2021)

A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells
por: Nishimura, Goshi, et al.
Publicado: (1999)

Systematic chemoenzymatic synthesis of O-sulfated sialyl Lewis x antigens
por: Santra, Abhishek, et al.
Publicado: (2016)

Comparison of human and mouse E-selectin binding to Sialyl-Lewis(x)
por: Rocheleau, Anne D., et al.
Publicado: (2016)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Understanding the tumor microenvironment in head and neck squamous cell carcinoma
por: Rad, Habib Sadeghi, et al.
Publicado: (2022)

Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Brandt, Anna, et al.
Publicado: (2023)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
por: Albers, A. E., et al.
Publicado: (2010)

A Novel Function of CD82/KAI1 in Sialyl Lewis Antigen-Mediated Adhesion of Cancer Cells: Evidence for an Anti-Metastasis Effect by Down-Regulation of Sialyl Lewis Antigens
por: Yoshihama, Naoya, et al.
Publicado: (2015)

Sialyl Lewis(X/A) and Cytokeratin Crosstalk in Triple Negative Breast Cancer
por: Pascoal, Carlota, et al.
Publicado: (2023)

Sialyl Lewis X Expression and Lymphatic Microvessel Density in Primary Tumors of Node-negative Colorectal Cancer Patients Predict Disease Recurrence
por: Doekhie, Fania S., et al.
Publicado: (2008)

Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
por: Elmusrati, Areeg, et al.
Publicado: (2021)

The tumor ecosystem in head and neck squamous cell carcinoma and advances in ecotherapy
por: Gong, Yingying, et al.
Publicado: (2023)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
por: Cristina, Valerie, et al.
Publicado: (2019)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma: a narrative review
por: Sharon, Shay, et al.
Publicado: (2022)

Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy
por: Laban, Simon, et al.
Publicado: (2017)

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma
por: Burgener, Justin M., et al.
Publicado: (2021)

The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer
por: Atiq, Saad O., et al.
Publicado: (2018)

Prostatic Cell-Specific Regulation of the Synthesis of MUC1-Associated Sialyl Lewis a
por: Chachadi, Vishwanath B., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_thaud5o2i3urebqvfchj4ruldo